Homology modelling and structure-based screening of phenylacetamide derivatives targeting KLK-15 implicated in prostate cancer angiogenesis
Current Trends in Biotechnology and Pharmacy · 07.04.2026 · 20 (2) · 2913-2934
DOI: 10.5530/ctbp.2026.2.16 ↗Kurz gefasst
Fachartikel in der Zeitschrift Current Trends in Biotechnology and Pharmacy, online erschienen am 07.04.2026. Verfasst von Jyothi Bandi und 1 weiteren Autor:innen.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Bandi, J., & Nambigari, N. (2026). Homology modelling and structure-based screening of phenylacetamide derivatives targeting KLK-15 implicated in prostate cancer angiogenesis. Current Trends in Biotechnology and Pharmacy, 20(2), 2913-2934. https://doi.org/10.5530/ctbp.2026.2.16
Vancouver
Bandi J, Nambigari N. Homology modelling and structure-based screening of phenylacetamide derivatives targeting KLK-15 implicated in prostate cancer angiogenesis. Current Trends in Biotechnology and Pharmacy. 2026;20(2):2913-2934. doi:10.5530/ctbp.2026.2.16
BibTeX
@article{Bandi2026,
author = {Bandi, Jyothi and Nambigari, Navaneetha},
title = {Homology modelling and structure-based screening of phenylacetamide derivatives targeting KLK-15 implicated in prostate cancer angiogenesis},
journal = {Current Trends in Biotechnology and Pharmacy},
year = {2026},
volume = {20},
number = {2},
pages = {2913--2934},
doi = {10.5530/ctbp.2026.2.16}
}
EUVIMED